We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Saliva Test Detects GHB and Alcohol Poisonings

By LabMedica International staff writers
Posted on 19 Jan 2016
A saliva-based test has been developed that offers the potential to screen for poisons commonly associated with the cheap or imitation manufacture of alcohol, and γ-hydroxybutyric acid, the so-called “date rape” drug GHB.

Treatment of poisoning from the consumption of ethanol and the management of the intoxicated patient represents a significant burden on many health services. More...
Further, poisoning from the consumption of other alcohols, notably methanol and ethylene glycol, occurs sporadically and from time to time outbreaks occur where food, drink or medicines are contaminated, resulting in significant mortality.

Scientists at Loughborough University (UK) and the University of Cordoba (Spain) added to the fresh saliva of volunteers and used a polydimethylsiloxane (PDMS) oral sampler to extract methanol, ethanol, ethylene glycol, 1,3-propandiol and γ-hydroxybutyric acid. The compounds were detected using gas chromatography-differential mobility spectrometry (GC-DMS). The extracted compounds were recovered by thermal desorption, isolated by gas chromatography and detected with differential mobility spectrometry, operating with a programmed dispersion field.

Calibration of the DMS under optimized conditions was undertaken using gas chromatography to introduce known on-column masses of the analytes injected in a solution of dichloromethane. The DMS used in the study was a planar device (SDP-1, Sionex Corporation, Bedford, MA, USA). Once the analytes had been added, the saliva standards were homogenized. Immediately after this had been done, a PDMS-coated titanium cartridge was removed from its sealed thermal desorption tube and placed into the vial, which was then sealed immediately.

C.L. Paul Thomas, PhD, a professor of Analytical Science, and coauthor of the study, said, “Many people attending accident and emergency departments have some kind of alcohol-related issue, particularly at the weekends. We're aiming to develop a test that is as simple as taking temperature with a thermometer that detects when patients are more than just drunk. We were surprised at the ease at which we could detect γ-hydroxybutyric acid. It's both a polar and acidic molecule, but it turned out to be easy to detect, even at the low concentrations we were studying.” The scientists are now working on running trials of their test in a clinical setting, on patients in emergency departments. The study was published on January 8, 2016, in the Journal of Breath Research.

Related Links:

Loughborough University 
University of Cordoba 




Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Pan-Cancer Panel
TruSight Oncology 500
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.